We are live on ! Find out more
SGRX icon

Sangrix

1 hedge funds and large institutions have $6.62K invested in Sangrix in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.12% less ownership

Funds ownership: 0.21% → 0.1% (-0.12%)

50% less funds holding

Funds holding: 2 → 1 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

81% less capital inflows, than outflows

Capital inflows: $9.9K | Capital outflows: $51K

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SGRX Hedge Fund Activity: Q2 2023 in Review

1 of the 6,391 institutional investors tracked by Wall St. Rank reported a position in Sangrix (SGRX) for Q2 2023, worth a combined $6.62K — down 87% from $52.7K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SGRX and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $9.9K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $26K sold.

  • 1 institutional investor held Sangrix (SGRX) as of Q2 2023, down from 2 in Q1 2023.
  • Funds reported $6.62K of Sangrix stock for Q2 2023, down 87% quarter-over-quarter.
  • 1 fund opened new Sangrix positions in Q2 2023 and 2 closed out, a net change of -1 holder.
  • The largest Sangrix buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $9.9K added.
  • The largest Sangrix seller in Q2 2023 was Renaissance Technologies, an estimated $26K sold.

Based on aggregated 13F filings for Q2 2023.